Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 – present)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 – present)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 23, Issue 2, Pages 189-202
Publisher
Informa Healthcare
Online
2012-12-12
DOI
10.1517/13543776.2013.743993
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells
- (2012) Di Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- S-1 for the treatment of gastrointestinal cancer
- (2012) Taroh Satoh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells
- (2012) Xue-Wei Yang et al. HEPATOLOGY RESEARCH
- Green Tea Consumption and Gastric Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population
- (2012) S. Sasazuki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Peracetylated (−)-Epigallocatechin-3-gallate (AcEGCG) Potently Suppresses Dextran Sulfate Sodium-Induced Colitis and Colon Tumorigenesis in Mice
- (2012) Yi-Shiou Chiou et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
- (2012) Kazushige Ishida et al. PLoS One
- Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study
- (2011) G. Yang et al. CARCINOGENESIS
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogs
- (2011) Sreedhar Pamu et al. MedChemComm
- Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope?
- (2010) Joseph Ciccolini et al. Clinical Colorectal Cancer
- Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors
- (2009) E. B. Golden et al. BLOOD
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Enhanced antitumor activities of (−)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo
- (2008) Kazuaki Matsumura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced anti-influenza A virus activity of (−)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: Effect of alkyl chain length
- (2008) Shuichi Mori et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effect of a Prodrug of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate on the Growth of Androgen-Independent Prostate Cancer In Vivo
- (2008) Suk-Ching Lee et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now